Enhancing cancer therapy: The potential of mercaptopurine-based nanomaterials for targeted drug delivery

Next Nanotechnology, Journal Year: 2023, Volume and Issue: 2, P. 100018 - 100018

Published: June 1, 2023

6-Mercaptopurine is a medication employed to treat autoimmune illnesses and cancer. However, due its poor solubility, quick metabolism, possible side effects, it not very effective. With advantages like better bioavailability, increased drug stability, targeted deliveries, nanomaterials have emerged as promising platform for delivery. This article addresses the possibility of treating cancer with based on mercaptopurine. Scientists investigated variety treatments, including use mercaptopurine, since disease one leading causes death in globe. The has been tested an adjuvant treatment colorectal shown cause remission patients acute lymphoblastic leukemia. Due their capacity boost uptake by cells, protect from degradation, lessen toxicity healthy tissues, liposomes, dendrimers, solid lipid nanoparticles potential mercaptopurine-based nanomaterials, gold nanoparticles, discussed several studies reviewed piece. review provides researchers latest progress 6-mercaptopurine loaded nanocarriers novel approach utilizing delivery Mercaptopurine therapy which show great advanced tool compared classic mercaptopurine drug.

Language: Английский

Neuro-Nanocarriers: Redefining Treatment Pathways for Brain Disorders

BioNanoScience, Journal Year: 2024, Volume and Issue: 15(1)

Published: Dec. 7, 2024

Language: Английский

Phytoreduced gold nanoparticles from vitalmelon promote white adipocyte browning in murine cells by targeting phospholipase D2

Journal of Photochemistry and Photobiology, Journal Year: 2024, Volume and Issue: 25, P. 100254 - 100254

Published: Dec. 10, 2024

Language: Английский